Last Seven Days

27 articles from the last seven days

• 
  Copycats hit PBS bottleneck

  Biosimilar and generic drugmakers have emerged as the top contenders to secure an October PBS listing, including one drug that could force a price cut for a $72 million-a-year blockbuster

  21 Sep 2026
• 
  New law gives patients driving exemption

  Medicinal cannabis patients in NSW will no longer have to choose between taking their medicine or driving after reforms abolish automatic license loss and heavy fines

  18 Sep 2026
• 
  Another Aussie CEO departs for 'personal reasons'

  Leaving after 24 years, this latest exit follows a string of CEO departures across Australia’s biotech sector

  18 Sep 2026
• 
  Amgen releases roadmap for post-cardiac care

  With a third of cardiac events being repeats, Amgen has co-authored a report to address gaps in post-hospital care

  18 Sep 2026
• 
  Policy 'earthquake' reshaping pharma

  In what's been described as the biggest industry transformation in 30 years, pharma is facing a 'commercialisation reset' on how it does business

  18 Sep 2026
• 
  Ex-pharma leader joins fast-growing agency

  A corporate and strategic communications advisory agency has buffed up its team with a former J&J and Novartis corporate affairs leader joining the ranks

  18 Sep 2026
• 
  Australia a key market for new platform

  Transforming Medical Information into a strategic source of intelligence for pharmas by unlocking more value from every scientific interaction

  18 Sep 2026